Evergreen and Vinnic Battery Works Ltd. proudly offers a variety of power solutions. Our batteries include: Alkaline, Zinc Chloride, Alkaline Manganese & Silver Oxide Button Cells, Lithium, Nickel Cadmium and Nickel Metal Hydride. Email us at sales@evergreencpusa.com and stop by our booth in Venetian Expo, Halls A-D – 51765 and say hi! | EVERGREEN (CP) USA is a battery manufacturer that has been offering high quality dry-cell batteries in the North, Central and South American market since 1986. We provide our customers with green energy solutions for their portable energy requirements by offering an extensive line of quality heavy duty, alkaline, button cell and rechargeable batteres.
Eureka Chemical Co./Fluid Film
Lawn & Garden equipment is in constant exposure to such highly corrosive substances as fertilizers, pesticides, heavy rains and high humidity. The best protection from these elements is a systematic maintenance program.
Cytovale
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Cytovale’s FDA-cleared IntelliSep sepsis test is pioneering a new way of quickly and accurately analyzing white blood cells (WBCs) to stratify a patient’s risk of sepsis from a standard blood draw in ~8 minutes. The IntelliSep test categorizes patients into three bands according to their probability of sepsis. The results may equip providers with a tool to optimize clinical outcomes and empower hospitals to improve resource utilization and achieve operational excellence. For more information, please visit our website: www.cytovale.com
Cureline, Inc.
Cureline Group is a global precision and translational medicine CRO providing preclinical and laboratory services to the biopharmaceutical industry since 2003. Cureline Group offers a full range of ISO-certified, CAP-compliant clinical research services (Biobanking, Histo/Digital and molecular pathology, small animal and POC validation) for biopharma researchers conducting preclinical and biomarker / companion diagnostics development projects. Cureline headquarters, based in California (USA), oversees global clinical operations and regulatory affairs in 20+ countries (US, EU, Eastern Europe, China, India, and South America). A preclinical studies center is in Vilnius, Lithuania. With our extensive experience, Cureline has successfully aided more than 850 clients globally. We offer top-notch support for preclinical, therapeutic, and diagnostic clinical trials, as well as implement complex research protocols for precision medicine programs. Our expertise extends to conducting molecular and cellular analyses and providing translational histology/pathology services. Visit www.CurelineGroup.com to learn more.
City of South San Francisco
. | South San Francisco is the birthplace of biotechnology, dating back to the founding of Genentech in 1976. Today, South San Francisco is home to one of the largest biotech clusters in the world. Over 250 biotech companies and 12 million square feet of biotech space form the anchor of South San Francisco’s economy. We have the nation’s premier life sciences workforce drawing from nearby universities, including the University of California, San Francisco, Stanford University, and the University of California, Berkeley. Even more exciting is the 3.5 million square feet of biotech space that is currently under construction. South San Francisco anticipated—and planned for—the rapid growth in the biotech cluster. We invested over $300 million toward street improvements, water quality and sewer delivery upgrades. We work closely with universities and our community college to sustain our talented workforce. Construction continued through—and after—2020. Between 2019 and 2035, the City of South San Francisco anticipates that square footage dedicated to the life science industry in South San Francisco will double. The City of South San Francisco is convenient. South San Francisco is less than 10 minutes from the San Francisco International Airport (SFO), 15 miles from the center of the City of San Francisco, and a half an hour from Stanford University in the heart of Silicon Valley. Quality of life in South San Francisco is high. Beaches in Pacifica and Ocean Beach are a short drive away. Daytrips to the world class skiing and hiking of the Sierra Nevada Mountain range are possible. The nearby City of San Francisco provides opportunities to attend world-class concerts and major league sporting events, just 7 miles away. The South San Francisco Unified School District (SSFUSD) is a nationally recognized leader in the Green Schools Movement. SSFUSD is home to four California Distinguished Schools and two California Gold Ribbon Schools. The City of South San Francisco is home to many modern amenities. A State-of-the-Art Library, Parks and Recreation building opened in 2023. Turf sports fields were installed at Orange Park in 2023. And a new aquatic center is under construction at Orange Park with a scheduled to opening in 2025. South San Francisco offers its citizens a city in which to live comfortably in fine residential areas; a place of recreation in parks, swimming pools and marinas; and a place to work in more than 2,800 firms and businesses, including over 250 biotech companies, such as Genentech, Merck, Pfizer, Astellas and Verily. Beyond our location advantages, the City of South San Francisco and our four Real Estate Investment Trust Companies have invested millions to create the climate for growth. Today, South San Francisco’s construction projects are changing the shape of biotech industry in the San Francisco Bay Area and California. Phase 1 of the 3 million square foot Southline campus is complete. South City Ventures 213,000 square foot building and Healthpeak’s 130,000 square foot building have anticipated completion dates in 2024. A majority of South San Francisco biotechnology companies belong to the medical sector, which involves researching and developing applications for drugs and therapies, as well as the manufacturing of medical devices and other research consumables. Sixty-one percent of the City’s biotech companies specialize in biopharmaceutical research and development (R&D) (e.g. vaccines, allergenic products, gene therapies, etc.). This reflects the high demand for R&D in the biopharma sector. South San Francisco can link you with companies in the ecosystem undertaking: -Next Generation Sequencing -Translational Medicine -Digital Health -Neurology and Aging -Data Analysis -Blending of High-Tech and Biotech research -And a thriving biopharma sector in the broader Bay Area. | x | We Are the Birthplace of Biotechnology -Biotechnology has been a major component of South San Francisco’s economy since the founding of Genentech in 1976. -South San Francisco is home to a talented & experienced workforce that draws from nearby colleges and universities, including Stanford University; the University of California, Berkeley; and the University of California, San Francisco. -Part of vibrant Bay Area venture capital ecosystem with over $6 billion in investments raised by the top 25 life science companies. -One of the Largest Biotech Clusters in the World. -Over 11 million square feet of space under construction or in planning.
ChemPartner
Over the past twenty years, ChemPartner has evolved from a pure chemistry service provider to a research innovation engine with a broad portfolio of services spanning from discovery through development in both small molecule and large molecule therapeutics.
California Life Sciences
California Life Sciences (CLS) is the state’s most influential and impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For more than 30 years, CLS has served the community by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in the fields of biotechnology, pharmaceuticals, and medical technology. As integral components of a healthy and collaborative ecosystem, CLS also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this vibrant sector. With offices in South San Francisco, San Diego, Sacramento, Los Angeles, and Washington DC, CLS works to shape public policy, improve access to breakthrough technologies, educate lawmakers, and advance equity within our ecosystem by championing innovative solutions for some of the most pressing challenges of our times. In doing so, CLS fulfills its mission to protect and nurture California’s life sciences industry, empowering discoveries that lead to healthier lives around the world. | California Life Sciences (CLS) is the state’s most impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For more than 30 years, CLS has served the community by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in the fields of biotechnology, pharmaceuticals, and medical technology. As integral components of a healthy and collaborative ecosystem, CLS also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this vibrant sector. With offices in South San Francisco, San Diego, Sacramento, Los Angeles, and Washington DC, CLS works to shape public policy, improve access to breakthrough technologies, educate lawmakers, and advance equity within our ecosystem by championing innovative solutions for some of the most pressing challenges of our times. In doing so, CLS fulfills its mission to protect and nurture California’s life sciences industry, empowering discoveries that lead to healthier lives around the world. | California Life Sciences (CLS) is the state’s leading advocacy organization for the life sciences. CLS advances public policy that promotes innovation and improves access to transformative technologies. With offices in South San Francisco, San Diego, Sacramento, Los Angeles, and Washington DC, CLS has spent the past 30 years supporting organizations of all sizes, from early-stage innovators and startups to established leaders in the fields of biotechnology, pharmaceuticals, and medical technology. CLS’ core mission is to advocate for a world class life sciences ecosystem in California, whose innovation leads to healthier lives around the world.
Calico Life Sciences
Calico (Calico Life Sciences LLC) is an Alphabet-founded research and development company whose mission is to harness advanced technologies and model systems to increase our understanding of the biology that controls human aging. Calico will use that knowledge to devise interventions that enable people to lead longer, healthier lives.Our development programs are focused on identifying new targets — areas of biology not widely pursued by others — based on our evolving insights into the mechanisms that drive decline in health over time. In nephrology, Calico and AbbVie are evaluating ABBV-CLS-628, an investigational human monoclonal antibody that inhibits PAPP-A, in a Phase 2 clinical trial (NCT06902558) for Autosomal Dominant Polycystic Kidney Disease (ADPKD). By modulating IGF signaling, ABBV-CLS-628 aims to slow disease progression in a disorder lacking targeted treatment options. The ongoing Phase 2 study is now enrolling across approximately 100 sites globally.
Biocompare
Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.